NEWS

   

EVENTS

Conferences

Molecular Biology and Medicine

MOLECULAR BIOLOGY AND MEDICINE

December 16-17, 2019
The molecular medicine perspective emphasizes cellular and molecular phenomena and interventions rather than the previous conceptual and observational focus on patients and their organs.

AGRICULTURAL BIOTECHNOLOGY & ENGINEERING

AGRICULTURAL BIOTECHNOLOGY & ENGINEERING

January 29-30, 2020
Agricultural Biotechnology & Engineering Conference 2020 is a great platform for learning, exchanging opinions, and expanding one’s network enabled by live presentations followed by dynamic questions & answers sessions as well as panel discussions and workshops with keynote speakers.

Plant Science & Physiology

PLANT SCIENCE & PHYSIOLOGY

February 17-18, 2020
Plant tissue culture is the growth of plant cells outermost an intact plant. It depends on maintaining plant tissue in lab conditions on a suitable nutrient medium. The culture can be sustained as a mass of undifferentiated cells for a broad area for a period of time, or regenerated into whole plant...

Industrial Biotechnology and Bioprocessing

INDUSTRIAL BIOTECHNOLOGY AND BIOPROCESSING

February 17-18, 2020
Through a series of plenary sessions, workshops and breakout sessions, Industrial Biotechnology 2020 will provide a rigorous review of novel therapies, bio-products as well as report on the very latest findings in industrial biotechnology and bioprocessing research.

Antibody Engineering & Therapeutics US

ANTIBODY ENGINEERING & THERAPEUTICS US

December 09-13, 2019
Add-on this pre-conference training course to your main conference registration package for an additional fee and gain a comprehensive overview of antibody engineering in an easy-to-follow classroom setting to help you prepare for the main conference program.

Genesis 2019 New Horizons in Life Science & Healthcare

GENESIS 2019 NEW HORIZONS IN LIFE SCIENCE & HEALTHCARE

December 11-11, 2019
Building on the evolution of the past 18 years, Genesis 2019 will assemble senior executives and decision makers from across the Life Science, Healthcare and Technology field to present, discuss and demonstrate their collective insight and thought leadership for the sector, themselves and their stak...

SiriusDecisions 2019 Technology Exchange

SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE

December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

Synthetic Biology UK 2019

SYNTHETIC BIOLOGY UK 2019

December 09-10, 2019
Synthetic biology is a convergence of multiple fields that can generate both improved understanding of biological systems as well as cutting-edge biotechnology.

 

Webinars

DEC 17, 2019
TRANSPORTATION SOLUTIONS FOR CELL & GENE THERAPY SUPPLY CHAINS
This webinar will help you understand how to start tackling your clinical supply chain.
JAN 15, 2020
REDUCING COMPLEXITY AND INCREASING THE VALUE OF MOLECULAR VL, STI, AND TRANSPLANT TESTING WITH MIDDLEWARE
This presentation will focus on a brief history of computing in the clinical laboratory, progress through some key middleware terms to know and understand, discuss some practical applications in the molecular laboratory and conclude with a brief list of best-in-class attributes to consider...
JAN 16, 2020
QUALIFICATION OF RAW MATERIALS AND CELL SUBSTRATES FOR BIOMANUFACTURING
The quality of starting materials is critical for successful pharmaceutical manufacturing strategies. For biomanufacturing the challenges are further amplified due to the use of a wide variety of raw materials, cell lines, and naturally-derived materials with an increased risk for the intr...
FEB 10, 2020
MAB INDUSTRY IN CHINA : BIOSIMILARS VS INNOVATIVE BIOLOGICS
Following patent cliffs for Erbitux, Rituxan, Sandosta_n and several big blockbusters, Herceptin, Avastin are now among the next biosimilar targets. This is creating huge potential for biosimilars, prompting innovators to shift their focus to target more emerging markets which remain untap...
FEB 19, 2020
PARALLEL DNA BASED CANNABIS TESTING OF MULTIPLE MICROBES
This Webinar will focus on the key attributes of DNA-based microbial testing, which can be usefully broken into 4 Basic Principles.
MAR 11, 2020 | 6:00am
NEUROSCIENCE 2020
LabRoots is excited to present the 8th Annual Neuroscience Virtual Conference, to be broadcasted live on March 11, 2020. This distinguished, online-only, event is free to attend and will once again bring together the neuroscience community to discuss and present the newest advances in unde...

PLANTS WITH SUPERPOWERS (GMO) WEBINAR
Sponsored
We’ve all seen non-GMO labels in the grocery store. What does GMO mean and why should we care? In this webinar, Biology Fortified will show how biotechnology can be used to give plants superpowers. We will discuss plant breeding methods, current and future GMO traits, GMO safety, and...
DNA METHYLATION CHANGES DURING CELL DIFFERENTIATION WEBINAR
Sponsored
Listen in as Dr Ballestar discusses an overall perspective on the connections between DNA methylation and other epigenetic marks, as well as the interplay with transcription factors.
THE POTENTIAL OF ENGINEERED HUMAN LIVER CO-CULTURES IN PHENOTYPIC DRUG DISCOVERY FOR LIVER DISEASES
The diverse functions of the liver (i.e. albumin synthesis, glucose and fatty acid metabolism, drug metabolism) can be severely compromised by several diseases. In particular, drug-induced liver injury is a leading cause of drug attrition; hepatitis B virus chronically infects the livers o...
COMBINING TRANSPORTER DATA WITH QUANTITATIVE SYSTEMS TOXICOLOGY MODELING (DILISYM) TO IMPACT DECISIONS IN DRUG DEVELOPMENT
A quantitative systems toxicology (QST) model of drug-induced liver injury (DILI) has been developed through the DILI-sim Initiative over the past 7 years to assist in the safety characterization of compounds in clinical development.  The emerging platform, DILIsym®, is capable of...
THE UTILITY OF MICROSCALE HUMAN LIVER CO-CULTURES FOR INVESTIGATING DRUG TOXICITY OUTCOMES
Drug-induced liver injury (DILI) remains a leading cause of acute liver failures and the attrition of pharmaceuticals in both preclinical and clinical settings. Due to species-specific differences in drug metabolism pathways, animal models do not always fully predict human DILI. Thus, ther...
ENGINEERING MICROPATTERNED CO-CULTURES FOR DRUG DEVELOPMENT
Due to significant differences across species in liver pathways, models of the human liver are used to screen for potential efficacy and/or toxicity of candidate compounds. Such models serve to complement and reduce the number of animals used in studies required by regulatory agencies. How...

RESOURCES

The pharmaceutical and medical industry suffers huge pain, high cost and poor results from conventional biological indicators. This new science of using Enzyme Indicators for measuring decontamination...

Biological processes arise from nature’s inherent complexity, and they involve many components connected with positive and negative feedback, sometimes with redundant circuitry, sometimes with d...

No other problem in cell culturing is as universal as microbial contamination. In order to avoidit, good sterile techniques and thorough culture handling are essential. Beyond that, the CO2 incubator ...

New medicines and diagnostics on the one hand and rising cost pressure as a result, for example, of the launch of generics and biosimilars on the other mean that new, highly efficient methods are requ...

During the cultivation of animal cells the monitoring of nutrients and metabolites has an important role for the controlling strategy of the cell culture. The measurement of glucose and lactate is one...

Design of experiments (DoE) is one of the most important techniques for systematic planning, execution and statistical evaluation of experiments. Although a DoE investigation is executable in one bior...

The development of biosimilars requires extensive physicochemical characterization of biosimilar candidate molecules which should match the quality profile of the reference molecule (originator). Here...

The presented data demonstrates that chemical denaturation is a feasible approach to predict the colloidal long-term stability of biologicals. Moreover, changes in G in dependence of the protein con...

It is the nirvana that Life Sciences organizations have been chasing for the past 30 years. The time is finally now. A digital transformation is taking place in the life sciences industry, from resear...